Evidence map›Paper›PMID 33234740›Full record

ArticleAging2020

Silencing hTERT attenuates cancer stem cell-like characteristics and radioresistance in the radioresistant nasopharyngeal carcinoma cell line CNE-2R.

Kaihua Chen, Ling Li, Song Qu, Xinbin Pan, Yongchu Sun, Fangzhu Wan, Binbin Yu, Lei Zhou, Xiaodong Zhu

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kaihua ChenDepartment of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, Guangxi, China.
Ling LiDepartment of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, Guangxi, China.
Song QuDepartment of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, Guangxi, China.
Xinbin PanDepartment of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, Guangxi, China.
Yongchu SunDepartment of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, Guangxi, China.
Fangzhu WanDepartment of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, Guangxi, China.
Binbin YuDepartment of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, Guangxi, China.
Lei ZhouDepartment of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, Guangxi, China.
Xiaodong ZhuDepartment of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning 530021, Guangxi, China.
Guangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to explore the effect of silencing hTERT on the CSC-like characteristics and radioresistance of CNE-2R cells.

resultsSilencing hTERT suppressed CNE-2R cell proliferation and increased the cell apoptosis rate and radiosensitivity

conclusionSilencing hTERT can suppress the CSC-like characteristics of CNE-2R cells to enhance their radiosensitivity, revealing that hTERT may become a potential target for treating radioresistant NPC.

methodsAn RNAi lentiviral vector specific to the hTERT gene was constructed to infect CNE-2R cells, the hTERT silencing effect was verified through qPCR and Western blot assays, and telomerase activity was detected by PCR-ELISA. Moreover, radiosensitivity

Indexed as

AnimalsApoptosisCell Line, TumorCell ProliferationHumansMiceMice, NudeNasopharyngeal CarcinomaNasopharyngeal NeoplasmsNeoplastic Stem CellsRadiation ToleranceTelomeraseXenograft Model Antitumor AssaysTelomerasecancer stem cellshTERTnasopharyngeal carcinomaradioresistanceRNA interference

Identifiers

PMID33234740
PMCPMC7803545
OpenAlexW3107050516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.